NCT00803920View on ClinicalTrials.gov

Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Type 2 Diabetes Mellitus
Trial Locations (1)

55416

International Diabetes Center, Minneapolis

Sponsors
All Listed Sponsors
collaborator

Amylin Pharmaceuticals, LLC.

INDUSTRY

lead

HealthPartners Institute

OTHER